Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2C19 Genotype-Based PPI Dosing in Erosive Esophagitis
NCT07843264Phase 4Not yet recruiting
- Sponsor
- University of Florida
- Start
- Oct 2026
- Primary completion
- Dec 2027
01
Overview
A Phase 4 trial of pantoprazole in erosive esophagitis (EE), sponsored by University of Florida. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
pantoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT07843264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843264.